The Complete Guide to Startup Valuation Methods
Understanding How VCs Value Early-Stage Companies
One of the most confusing parts of startup investing is valuation. A company with no revenue can be worth $5M or $50M depending on the method used. Here's how to navigate it.
Why Valuation Methods Matter
Founders need to understand valuation to negotiate fair terms. Investors need to understand valuation to avoid overpaying. Both sides use these methods, which means knowing them gives you an edge in any negotiation.
The 5 Main Valuation Methods
1. Berkus Method
Best for: Pre-revenue startups Developed by: Dave Berkus, angel investor
The Berkus method assigns a dollar value to each milestone achieved:
| Milestone | Typical Value |
|---|---|
| Sound idea (basic value) | $100K-$250K |
| Prototype (reduces technology risk) | $100K-$250K |
| Quality management team (reduces execution risk) | $100K-$250K |
| Strategic relationships (reduces market risk) | $100K-$250K |
| Product launched or committed (reduces product risk) | $100K-$250K |
Maximum valuation: $2.5M (5 milestones × $500K)
When to use: Seed rounds, solo GP checks under $50K, first-time founders without traction.
2. Scorecard Method (Portland Method)
Best for: Comparing your deal against industry averages Developed by: Angel投资人 association
Step 1: Find the average pre-money valuation for your stage/region/sector.
Step 2: Score your startup against average on these factors:
| Factor | Weight | Score (0-1.0) |
|---|---|---|
| Strength of management team | 30% | |
| Size of opportunity | 25% | |
| Product/technology | 15% | |
| Competitive landscape | 15% | |
| Marketing/sales/channel | 10% | |
| Need for additional capital | 5% |
Step 3: Multiply average valuation by your weighted score.
Example:
- Average seed valuation in your sector: $2M
- Your team is stronger than average (0.8) but product is average (0.5)
- Score: (0.8×0.30) + (0.5×0.25) + (0.5×0.15) + (0.5×0.15) + (0.5×0.10) + (0.5×0.05) = 0.575
- Adjusted valuation: $2M × 0.575 = $1.15M
3. Risk Factor Summation Method
Best for: Deals with specific, identifiable risks
Start with a baseline valuation, then add or subtract based on risk factors:
| Risk Factor | Adjustment |
|---|---|
| Management risk | ±$250K |
| Technology/dev stage risk | ±$250K |
| Market risk | ±$250K |
| Sales/marketing risk | ±$250K |
| Funding risk | ±$250K |
| Regulatory/political risk | ±$250K |
| Exit/harvest risk | ±$250K |
Example:
- Base valuation: $2M
- Strong team (+$250K), unproven tech (-$250K), small market (-$250K)
- Final valuation: $2M + $250K - $250K - $250K = $1.75M
4. Discounted Cash Flow (DCF)
Best for: Later-stage companies with predictable revenue
DCF is controversial for early-stage because it requires predicting cash flows 5-10 years out. Most early-stage VCs don't use it.
The formula:
Present Value = CF1 / (1+r)¹ + CF2 / (1+r)² + ... + CFn / (1+r)^n
Where:
- CF = Expected cash flow
- r = Discount rate (typically 25-40% for startups)
- n = Number of years
Why it's problematic for startups:
- Revenue is unpredictable
- Exit timing is uncertain
- Terminal value dominates
When it matters: Growth equity ($10M+ rounds), revenue-stage companies.
5. Comparable Transaction Method
Best for: Any stage, but more reliable for later stages
Look at what similar companies sold for recently:
- Find 5-10 comparable deals (same sector, stage, geography)
- Note the valuation and the metric (revenue, users, ARR)
- Calculate the multiple (e.g., 10x revenue)
- Apply that multiple to your company
Key multiples by stage:
| Stage | Typical Revenue Multiple |
|---|---|
| Pre-seed | No revenue - use other methods |
| Seed | 2-5x ARR (if ARR exists) |
| Series A | 5-10x ARR |
| Series B | 8-15x ARR |
| Growth | 10-20x ARR |
Data sources:
- Crunchbase
- PitchBook
- Mattermark -CB Insights
The Venture Capital Method
Best for: Angels and early VCs
Not a valuation method per se, but a back-of-envelope calculation:
- Estimate the company's value at exit (5-7 years out)
- Determine your target return (10x for angels)
- Work backward to today's valuation
Example:
- Target: $50M exit in 6 years
- Target return: 10x
- Your check: $500K
- Pre-money valuation: $5M - $500K = $4.5M
Decision Matrix: Which Method to Use
| Stage | Primary Method | Secondary |
|---|---|---|
| Pre-seed (<$500K) | Berkus | Risk Factor |
| Seed ($500K-$2M) | Scorecard | Berkus |
| Series A ($2M-$10M) | Comparable | DCF |
| Series B+ | Comparable | DCF |
The Math Problem with Post-Money SAFEs
Founders often confuse pre-money and post-money valuations with SAFEs.
Simple SAFE (no cap):
- Investment: $100K
- Post-money valuation: $4M
- Your ownership: $100K / $4M = 2.5%
SAFE with cap:
- Investment: $100K
- Cap: $2M
- Post-money: $2M + $100K = $2.1M
- Your ownership: $100K / $2.1M = 4.76%
The dilution trap: If the next round is at $6M pre-money:
- Previous SAFE holders at $2M cap get: $2M / $6M = 33% (capped)
- New investors get: 67%
- Founder gets: diluted from ~95% to ~63%
Red Flags in Valuation Discussions
For founders:
- Investor claims "this is just how it's done" without explanation
- Valuation based on "market standards" without data
- Down round disguised as "structured preferred"
- Liquidation preference > 1x
For investors:
- Pre-money valuation that doesn't match comparable transactions
- Founder refusing to disclose previous raise terms
- Circular valuations (using this round to value itself)
How to Negotiate Valuation
-
Know your BATNA - What's your alternative if this deal falls through?
-
Lead with data - Use comparable transactions to justify your number
-
Consider the whole term sheet - A higher valuation with worse terms can be worse than a lower valuation with founder-friendly terms
-
Think about signal - Taking a down round signals distress; taking a flat round signals steady progress
-
Know when to fold - If valuation is non-negotiable and you're overvalued, walking away is sometimes the right move
Key Takeaways
- No single method is correct - Use 2-3 methods and triangulate
- Stage matters - Pre-seed uses different methods than Series B
- Negotiation is part of the method - The "correct" valuation is usually a range
- Terms matter as much as valuation - A 2x liquidation preference changes everything
- Document everything - Cap table confusion is a startup killer
Tools and Resources
This article is part of SoloAnalyst's due diligence framework. For automated valuation analysis, try our free tool.